{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:30:45Z","timestamp":1793226645325,"version":"4.5.0"},"reference-count":130,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"US National Academy of Medicine (NAM) Healthy Longevity Catalyst Award 2021"},{"name":"\u201cAn Artificial Intelligence (AI)-driven Causal Approach for Early Diagnosis and Treatment of Late Onset Alzheimer\u2019s Disease\u201d under Seed Fund for Collaborative Research, The University of Hong Kong"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-85947-7","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T10:54:19Z","timestamp":1736938459000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["DeepDrug as an expert guided and AI driven drug repurposing methodology for selecting the lead combination of drugs for Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"15","author":[{"given":"Victor O. K.","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tushar","family":"Kaistha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn","family":"Downey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Illana","family":"Gozes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline C. K.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,15]]},"reference":[{"key":"85947_CR1","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S1474-4422(18)30403-4","volume":"18","author":"E Nichols","year":"2019","unstructured":"Nichols, E. et al. Global, regional, and national burden of Alzheimer\u2019s disease and other dementias, 1990\u20132016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 18, 88\u2013106 (2019).","journal-title":"Lancet Neurol."},{"key":"85947_CR2","unstructured":"Prince, M. J. et al. World Alzheimer Report 2015-The Global Impact of Dementia: An analysis of prevalence, incidence, cost and trends. (2015)."},{"key":"85947_CR3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jalz.2012.11.007","volume":"9","author":"M Prince","year":"2013","unstructured":"Prince, M. et al. The global prevalence of dementia: A systematic review and metaanalysis. Alzheimer\u2019s Dement. 9, 63-75.e62 (2013).","journal-title":"Alzheimer\u2019s Dement."},{"key":"85947_CR4","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nrneurol.2017.63","volume":"13","author":"Y-T Wu","year":"2017","unstructured":"Wu, Y.-T. et al. The changing prevalence and incidence of dementia over time\u2014Current evidence. Nat. Rev. Neurol. 13, 327\u2013339 (2017).","journal-title":"Nat. Rev. Neurol."},{"key":"85947_CR5","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/nature02621","volume":"430","author":"MP Mattson","year":"2004","unstructured":"Mattson, M. P. Pathways towards and away from Alzheimer\u2019s disease. Nature 430, 631\u2013639 (2004).","journal-title":"Nature"},{"key":"85947_CR6","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nrn1495","volume":"5","author":"M Citron","year":"2004","unstructured":"Citron, M. Strategies for disease modification in Alzheimer\u2019s disease. Nat. Rev. Neurosci. 5, 677\u2013685 (2004).","journal-title":"Nat. Rev. Neurosci."},{"key":"85947_CR7","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/nri1843","volume":"6","author":"HL Weiner","year":"2006","unstructured":"Weiner, H. L. & Frenkel, D. Immunology and immunotherapy of Alzheimer\u2019s disease. Nat. Rev. Immunol. 6, 404\u2013416 (2006).","journal-title":"Nat. Rev. Immunol."},{"key":"85947_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-021-00269-y","volume":"7","author":"DS Knopman","year":"2021","unstructured":"Knopman, D. S. et al. Alzheimer disease. Nat. Rev. Dis. Primers 7, 1\u201321 (2021).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"85947_CR9","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nrd2314","volume":"6","author":"I Melnikova","year":"2007","unstructured":"Melnikova, I. Therapies for Alzheimer\u2019s disease. Nat. Rev. Drug Discov. 6, 341\u2013342 (2007).","journal-title":"Nat. Rev. Drug Discov."},{"key":"85947_CR10","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41582-018-0013-z","volume":"14","author":"EE Congdon","year":"2018","unstructured":"Congdon, E. E. & Sigurdsson, E. M. Tau-targeting therapies for Alzheimer disease. Nat. Rev. Neurol. 14, 399\u2013415 (2018).","journal-title":"Nat. Rev. Neurol."},{"key":"85947_CR11","doi-asserted-by":"publisher","first-page":"5629","DOI":"10.1007\/s11033-021-06512-9","volume":"48","author":"T Athar","year":"2021","unstructured":"Athar, T., Al Balushi, K. & Khan, S. A. Recent advances on drug development and emerging therapeutic agents for Alzheimer\u2019s disease. Mol. Biol. Rep. 48, 5629\u20135645 (2021).","journal-title":"Mol. Biol. Rep."},{"key":"85947_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-022-10202-2","volume":"12","author":"B Bogdanovic","year":"2022","unstructured":"Bogdanovic, B., Eftimov, T. & Simjanoska, M. In-depth insights into Alzheimer\u2019s disease by using explainable machine learning approach. Sci. Rep. 12, 1\u201326 (2022).","journal-title":"Sci. Rep."},{"key":"85947_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/d41573-020-00217-7","volume":"20","author":"A Mullard","year":"2021","unstructured":"Mullard, A. Failure of first anti-tau antibody in Alzheimer disease highlights risks of history repeating. Nat. Rev. Drug Discov. 20, 3\u20136 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"85947_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-017-0329-8","volume":"10","author":"K-X Dou","year":"2018","unstructured":"Dou, K.-X. et al. Comparative safety and effectiveness of cholinesterase inhibitors and memantine for Alzheimer\u2019s disease: A network meta-analysis of 41 randomized controlled trials. Alzheimer\u2019s Res. Ther. 10, 1\u201310 (2018).","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"85947_CR15","unstructured":"National Institute for Health and Care Excellence (NICE). In: Dementia: Assessment, management and support for people living with dementia and their carers (2018)."},{"key":"85947_CR16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"S Pushpakom","year":"2019","unstructured":"Pushpakom, S. et al. Drug repurposing: Progress, challenges and recommendations. Nat. Rev. Drug Discov. 18, 41\u201358 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"85947_CR17","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41563-019-0338-z","volume":"18","author":"S Ekins","year":"2019","unstructured":"Ekins, S. et al. Exploiting machine learning for end-to-end drug discovery and development. Nat. Mater. 18, 435\u2013441 (2019).","journal-title":"Nat. Mater."},{"key":"85947_CR18","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/s41582-020-0397-4","volume":"16","author":"C Ballard","year":"2020","unstructured":"Ballard, C. et al. Drug repositioning and repurposing for Alzheimer disease. Nat. Rev. Neurol. 16, 661\u2013673 (2020).","journal-title":"Nat. Rev. Neurol."},{"key":"85947_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-020-00736-w","volume":"13","author":"A Ancidoni","year":"2021","unstructured":"Ancidoni, A. et al. Anticancer drugs repurposed for Alzheimer\u2019s disease: A systematic review. Alzheimer\u2019s Res. Ther. 13, 1\u201315 (2021).","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"85947_CR20","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/nrd3869","volume":"11","author":"A Corbett","year":"2012","unstructured":"Corbett, A. et al. Drug repositioning for Alzheimer\u2019s disease. Nat. Rev. Drug Discov. 11, 833\u2013846 (2012).","journal-title":"Nat. Rev. Drug Discov."},{"key":"85947_CR21","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/nm.3595","volume":"20","author":"SM Strittmatter","year":"2014","unstructured":"Strittmatter, S. M. Old drugs learn new tricks. Nat. Med. 20, 590\u2013591 (2014).","journal-title":"Nat. Med."},{"key":"85947_CR22","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/nbt.2758","volume":"31","author":"Z-Y Wang","year":"2013","unstructured":"Wang, Z.-Y. & Zhang, H.-Y. Rational drug repositioning by medical genetics. Nat. Biotechnol. 31, 1080\u20131082 (2013).","journal-title":"Nat. Biotechnol."},{"key":"85947_CR23","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41746-019-0191-0","volume":"2","author":"M Uddin","year":"2019","unstructured":"Uddin, M., Wang, Y. & Woodbury-Smith, M. Artificial intelligence for precision medicine in neurodevelopmental disorders. Npj Digit. Med. 2, 112 (2019).","journal-title":"Npj Digit. Med."},{"key":"85947_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-10744-6","volume":"10","author":"F Cheng","year":"2019","unstructured":"Cheng, F. et al. A genome-wide positioning systems network algorithm for in silico drug repurposing. Nat. Commun. 10, 1\u201314 (2019).","journal-title":"Nat. Commun."},{"key":"85947_CR25","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/B978-0-12-802208-5.00014-X","volume-title":"Drug Discovery in Cancer Epigenetics","author":"NJ-M Raynal","year":"2016","unstructured":"Raynal, N.J.-M. Drug Discovery in Cancer Epigenetics 347\u2013371 (Elsevier, 2016)."},{"key":"85947_CR26","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.drudis.2016.05.015","volume":"21","author":"W Sun","year":"2016","unstructured":"Sun, W., Sanderson, P. E. & Zheng, W. Drug combination therapy increases successful drug repositioning. Drug Discov. Today 21, 1189\u20131195 (2016).","journal-title":"Drug Discov. Today"},{"key":"85947_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-09692-y","volume":"10","author":"F Cheng","year":"2019","unstructured":"Cheng, F., Kov\u00e1cs, I. A. & Barab\u00e1si, A.-L. Network-based prediction of drug combinations. Nat. Commun. 10, 1\u201311 (2019).","journal-title":"Nat. Commun."},{"key":"85947_CR28","doi-asserted-by":"publisher","first-page":"100737","DOI":"10.1016\/j.xcrm.2022.100737","volume":"3","author":"J Larkins-Ford","year":"2022","unstructured":"Larkins-Ford, J., Degefu, Y. N., Van, N., Sokolov, A. & Aldridge, B. B. Design principles to assemble drug combinations for effective tuberculosis therapy using interpretable pairwise drug response measurements. Cell Rep. Med. 3, 100737 (2022).","journal-title":"Cell Rep. Med."},{"key":"85947_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-21056-z","volume":"12","author":"A Belyaeva","year":"2021","unstructured":"Belyaeva, A. et al. Causal network models of SARS-CoV-2 expression and aging to identify candidates for drug repurposing. Nat. Commun. 12, 1\u201313 (2021).","journal-title":"Nat. Commun."},{"key":"85947_CR30","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41746-022-00561-5","volume":"5","author":"R Howell","year":"2022","unstructured":"Howell, R. et al. Executable network of SARS-CoV-2-host interaction predicts drug combination treatments. Npj Digit. Med. 5, 18 (2022).","journal-title":"Npj Digit. Med."},{"key":"85947_CR31","doi-asserted-by":"crossref","unstructured":"Gysi, D. M. et al. Network medicine framework for identifying drug-repurposing opportunities for COVID-19. Proc. Natl. Acad. Sci. 118 (2021).","DOI":"10.1073\/pnas.2025581118"},{"key":"85947_CR32","doi-asserted-by":"publisher","first-page":"23179","DOI":"10.1038\/s41598-021-02353-5","volume":"11","author":"K Hsieh","year":"2021","unstructured":"Hsieh, K. et al. Drug repurposing for COVID-19 using graph neural network and harmonizing multiple evidence. Sci. Rep. 11, 23179. https:\/\/doi.org\/10.1038\/s41598-021-02353-5 (2021).","journal-title":"Sci. Rep."},{"key":"85947_CR33","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1093\/bib\/bbv048","volume":"17","author":"JC Siavelis","year":"2016","unstructured":"Siavelis, J. C., Bourdakou, M. M., Athanasiadis, E. I., Spyrou, G. M. & Nikita, K. S. Bioinformatics methods in drug repurposing for Alzheimer\u2019s disease. Brief. Bioinform. 17, 322\u2013335 (2016).","journal-title":"Brief. Bioinform."},{"key":"85947_CR34","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/s43587-021-00122-7","volume":"1","author":"A Taubes","year":"2021","unstructured":"Taubes, A. et al. Experimental and real-world evidence supporting the computational repurposing of bumetanide for APOE4-related Alzheimer\u2019s disease. Nat. Aging 1, 932\u2013947 (2021).","journal-title":"Nat. Aging"},{"key":"85947_CR35","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/s12967-023-04192-6","volume":"21","author":"A Bayraktar","year":"2023","unstructured":"Bayraktar, A. et al. Drug repositioning targeting glutaminase reveals drug candidates for the treatment of Alzheimer\u2019s disease patients. J. Transl. Med. 21, 332 (2023).","journal-title":"J. Transl. Med."},{"key":"85947_CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-020-00736-w","volume":"13","author":"Y Zhou","year":"2021","unstructured":"Zhou, Y. et al. AlzGPS: A genome-wide positioning systems platform to catalyze multi-omics for Alzheimer\u2019s drug discovery. Alzheimer\u2019s Res. Ther. 13, 1\u201313 (2021).","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"85947_CR37","doi-asserted-by":"publisher","first-page":"e0304410","DOI":"10.1371\/journal.pone.0304410","volume":"19","author":"Z Azizan","year":"2024","unstructured":"Azizan, Z., Zali, H., Mirmotalebisohi, S. A., Bazrgar, M. & Ahmadiani, A. Deciphering molecular bridges: Unveiling the interplay between metabolic syndrome and Alzheimer\u2019s disease through a systems biology approach and drug repurposing. Plos One 19, e0304410 (2024).","journal-title":"Plos One"},{"key":"85947_CR38","doi-asserted-by":"crossref","unstructured":"Cheng, F. et al. Artificial intelligence and open science in discovery of disease-modifying medicines for Alzheimer\u2019s disease. Cell Rep. Med. 5 (2024).","DOI":"10.1016\/j.xcrm.2023.101379"},{"key":"85947_CR39","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1007\/s12031-021-01865-z","volume":"71","author":"VOK Li","year":"2021","unstructured":"Li, V. O. K. et al. Designing a protocol adopting an artificial intelligence (AI)\u2013driven approach for early diagnosis of late-onset Alzheimer\u2019s disease. J. Mol. Neurosci. 71, 1329\u20131337 (2021).","journal-title":"J. Mol. Neurosci."},{"key":"85947_CR40","doi-asserted-by":"publisher","first-page":"18332","DOI":"10.1038\/s41598-022-22822-9","volume":"12","author":"S Ghiam","year":"2022","unstructured":"Ghiam, S., Eslahchi, C., Shahpasand, K., Habibi-Rezaei, M. & Gharaghani, S. Identification of repurposed drugs targeting significant long non-coding RNAs in the cross-talk between diabetes mellitus and Alzheimer\u2019s disease. Sci. Rep. 12, 18332 (2022).","journal-title":"Sci. Rep."},{"key":"85947_CR41","doi-asserted-by":"publisher","first-page":"5191","DOI":"10.1093\/bioinformatics\/btz418","volume":"35","author":"X Zeng","year":"2019","unstructured":"Zeng, X. et al. deepDR: A network-based deep learning approach to in silico drug repositioning. Bioinformatics 35, 5191\u20135198 (2019).","journal-title":"Bioinformatics"},{"key":"85947_CR42","doi-asserted-by":"publisher","first-page":"111717","DOI":"10.1016\/j.celrep.2022.111717","volume":"41","author":"J Xu","year":"2022","unstructured":"Xu, J. et al. Interpretable deep learning translation of GWAS and multi-omics findings to identify pathobiology and drug repurposing in Alzheimer\u2019s disease. Cell Rep. 41, 111717 (2022).","journal-title":"Cell Rep."},{"key":"85947_CR43","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/j.csbj.2023.02.004","volume":"21","author":"X Pan","year":"2023","unstructured":"Pan, X. et al. AI-DrugNet: A network-based deep learning model for drug repurposing and combination therapy in neurological disorders. Computat. Struct. Biotechnol. J. 21, 1533\u20131542 (2023).","journal-title":"Computat. Struct. Biotechnol. J."},{"key":"85947_CR44","doi-asserted-by":"crossref","unstructured":"Hsieh, K.-L. et al. Synthesize heterogeneous biological knowledge via representation learning for Alzheimer\u2019s disease drug repurposing. iScience 26 (2023).","DOI":"10.1016\/j.isci.2022.105678"},{"key":"85947_CR45","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41593-020-0599-5","volume":"23","author":"R Sims","year":"2020","unstructured":"Sims, R., Hill, M. & Williams, J. The multiplex model of the genetics of Alzheimer\u2019s disease. Nat. Neurosci. 23, 311\u2013322 (2020).","journal-title":"Nat. Neurosci."},{"key":"85947_CR46","unstructured":"Bellenguez, C. et al. New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias. Nat. Genet. 1\u201325 (2022)."},{"key":"85947_CR47","doi-asserted-by":"crossref","unstructured":"Herrup, K. Fallacies in neuroscience: The Alzheimer\u2019s edition. Eneuro 9 (2022).","DOI":"10.1523\/ENEURO.0530-21.2021"},{"key":"85947_CR48","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1186\/s12918-015-0243-2","volume":"10","author":"H Yu","year":"2016","unstructured":"Yu, H. et al. Prediction of drugs having opposite effects on disease genes in a directed network. BMC Syst. Biol. 10, S2 (2016).","journal-title":"BMC Syst. Biol."},{"key":"85947_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-21330-0","volume":"12","author":"S Rodriguez","year":"2021","unstructured":"Rodriguez, S. et al. Machine learning identifies candidates for drug repurposing in Alzheimer\u2019s disease. Nat. Commun. 12, 1\u201313 (2021).","journal-title":"Nat. Commun."},{"key":"85947_CR50","doi-asserted-by":"publisher","DOI":"10.1080\/00207454.2022.2151712","author":"S Sui","year":"2022","unstructured":"Sui, S. & Lv, H. Cognitive Improving Actions of Tofacitinib in a mouse model of Alzheimer disease involving TNF-\u03b1, IL-6, PI3K-Akt and GSK-3\u03b2 signalling pathway. Int. J. Neurosci. https:\/\/doi.org\/10.1080\/00207454.2022.2151712 (2022).","journal-title":"Int. J. Neurosci."},{"key":"85947_CR51","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1177\/09727531211070532","volume":"28","author":"M Jain","year":"2021","unstructured":"Jain, M. et al. Role of JAK\/STAT in the neuroinflammation and its association with neurological disorders. Ann. Neurosci. 28, 191\u2013200 (2021).","journal-title":"Ann. Neurosci."},{"key":"85947_CR52","doi-asserted-by":"publisher","first-page":"e226567","DOI":"10.1001\/jamanetworkopen.2022.6567","volume":"5","author":"RJ Desai","year":"2022","unstructured":"Desai, R. J. et al. Comparative risk of Alzheimer disease and related dementia among medicare beneficiaries with rheumatoid arthritis treated with targeted disease-modifying antirheumatic agents. JAMA Netw. Open 5, e226567. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.6567 (2022).","journal-title":"JAMA Netw. Open"},{"key":"85947_CR53","doi-asserted-by":"publisher","first-page":"852802","DOI":"10.3389\/fphar.2022.852802","volume":"13","author":"M Vomero","year":"2022","unstructured":"Vomero, M. et al. Tofacitinib decreases autophagy of fibroblast-like synoviocytes from rheumatoid arthritis patients. Front. Pharmacol. 13, 852802 (2022).","journal-title":"Front. Pharmacol."},{"key":"85947_CR54","doi-asserted-by":"publisher","first-page":"1281338","DOI":"10.3389\/fnagi.2023.1281338","volume":"15","author":"H Barmaki","year":"2023","unstructured":"Barmaki, H., Nourazarian, A. & Khaki-Khatibi, F. Proteostasis and neurodegeneration: A closer look at autophagy in Alzheimer\u2019s disease. Front. Aging Neurosci. 15, 1281338 (2023).","journal-title":"Front. Aging Neurosci."},{"key":"85947_CR55","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/brain\/124.2.247","volume":"124","author":"T Shallice","year":"2001","unstructured":"Shallice, T. `Theory of mind\u2019 and the prefrontal cortex. Brain 124, 247\u2013248. https:\/\/doi.org\/10.1093\/brain\/124.2.247 (2001).","journal-title":"Brain"},{"key":"85947_CR56","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-024-04130-7","author":"D Advani","year":"2024","unstructured":"Advani, D. & Kumar, P. Uncovering cell cycle dysregulations and associated mechanisms in cancer and neurodegenerative disorders: A Glimpse of Hope for repurposed drugs. Mol. Neurobiol. https:\/\/doi.org\/10.1007\/s12035-024-04130-7 (2024).","journal-title":"Mol. Neurobiol."},{"key":"85947_CR57","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/j.1471-4159.2009.06296.x","volume":"111","author":"S Goldberg","year":"2009","unstructured":"Goldberg, S., Visochek, L., Giladi, E., Gozes, I. & Cohen-Armon, M. PolyADP-ribosylation is required for long-term memory formation in mammals. J. Neurochem. 111, 72\u201379 (2009).","journal-title":"J. Neurochem."},{"key":"85947_CR58","doi-asserted-by":"publisher","first-page":"7420","DOI":"10.1523\/JNEUROSCI.0333-05.2005","volume":"25","author":"L Visochek","year":"2005","unstructured":"Visochek, L. et al. PolyADP-ribosylation is involved in neurotrophic activity. J. Neurosci. 25, 7420\u20137428 (2005).","journal-title":"J. Neurosci."},{"key":"85947_CR59","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1080\/15548627.2019.1615823","volume":"15","author":"JM Carosi","year":"2019","unstructured":"Carosi, J. M. & Sargeant, T. J. Rapamycin and Alzheimer disease: A double-edged sword?. Autophagy 15, 1460\u20131462. https:\/\/doi.org\/10.1080\/15548627.2019.1615823 (2019).","journal-title":"Autophagy"},{"key":"85947_CR60","doi-asserted-by":"publisher","first-page":"4107","DOI":"10.1038\/s41598-020-60682-3","volume":"10","author":"Z Hu","year":"2020","unstructured":"Hu, Z. et al. Shared causal paths underlying Alzheimer\u2019s dementia and type 2 diabetes. Sci. Rep. 10, 4107 (2020).","journal-title":"Sci. Rep."},{"key":"85947_CR61","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1038\/s41467-023-38602-6","volume":"14","author":"A Topiwala","year":"2023","unstructured":"Topiwala, A. et al. Association of gout with brain reserve and vulnerability to neurodegenerative disease. Nat. Commun. 14, 2844 (2023).","journal-title":"Nat. Commun."},{"key":"85947_CR62","unstructured":"Zhang, X.-X. et al. Association of Vitamin D Levels with Risk of Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis of Prospective Studies. J. Alzheimer\u2019s Dis. 1\u201313 (2024)."},{"key":"85947_CR63","doi-asserted-by":"publisher","first-page":"18333","DOI":"10.1038\/s41598-021-97225-3","volume":"11","author":"L de Oliveira Neto","year":"2021","unstructured":"de Oliveira Neto, L. et al. Factors associated with inflamm-aging in institutionalized older people. Sci. Rep. 11, 18333 (2021).","journal-title":"Sci. Rep."},{"key":"85947_CR64","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1212\/WNL.0000000000002171","volume":"85","author":"VW Henderson","year":"2015","unstructured":"Henderson, V. W. et al. Raloxifene for women with Alzheimer disease: A randomized controlled pilot trial. Neurology 85, 1937\u20131944 (2015).","journal-title":"Neurology"},{"key":"85947_CR65","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13195-022-01020-9","volume":"14","author":"NR Johnson","year":"2022","unstructured":"Johnson, N. R. et al. Imipramine and olanzapine block apoE4-catalyzed polymerization of A\u03b2 and show evidence of improving Alzheimer\u2019s disease cognition. Alzheimer\u2019s Res. Ther. 14, 88 (2022).","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"85947_CR66","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.brainresbull.2009.09.003","volume":"81","author":"X-Z Zhang","year":"2010","unstructured":"Zhang, X.-Z., Li, X.-J. & Zhang, H.-Y. Valproic acid as a promising agent to combat Alzheimer\u2019s disease. Brain Res. Bull. 81, 3\u20136 (2010).","journal-title":"Brain Res. Bull."},{"key":"85947_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lfs.2014.01.083","volume":"101","author":"M Rivera-Oliver","year":"2014","unstructured":"Rivera-Oliver, M. & D\u00edaz-R\u00edos, M. Using caffeine and other adenosine receptor antagonists and agonists as therapeutic tools against neurodegenerative diseases: A review. Life Sci. 101, 1\u20139 (2014).","journal-title":"Life Sci."},{"key":"85947_CR68","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/s41419-020-2619-5","volume":"11","author":"IJ Yeo","year":"2020","unstructured":"Yeo, I. J., Yun, J., Son, D. J., Han, S.-B. & Hong, J. T. Antifungal drug miconazole ameliorated memory deficits in a mouse model of LPS-induced memory loss through targeting iNOS. Cell Death Dis. 11, 623 (2020).","journal-title":"Cell Death Dis."},{"key":"85947_CR69","doi-asserted-by":"publisher","first-page":"100745","DOI":"10.1016\/j.xcrm.2022.100745","volume":"3","author":"S Patterson","year":"2022","unstructured":"Patterson, S. & Palmer, A. Predicting in vivo activity of combination therapies from in vitro drug pairs in diverse environments. Cell Rep. Med. 3, 100745 (2022).","journal-title":"Cell Rep. Med."},{"key":"85947_CR70","doi-asserted-by":"publisher","first-page":"104052","DOI":"10.1016\/j.drudis.2024.104052","volume":"29","author":"M Pereira","year":"2024","unstructured":"Pereira, M., Cruz, M. T., Fortuna, A. & Bicker, J. Restoring the epigenome in Alzheimer\u2019s disease: Advancing HDAC inhibitors as therapeutic agents. Drug Discov. Today 29, 104052 (2024).","journal-title":"Drug Discov. Today"},{"key":"85947_CR71","doi-asserted-by":"publisher","first-page":"e2218915120","DOI":"10.1073\/pnas.2218915120","volume":"120","author":"Y Qiu","year":"2023","unstructured":"Qiu, Y. et al. Definition of the contribution of an Osteopontin-producing CD11c+ microglial subset to Alzheimer\u2019s disease. Proc. Natl. Acad. Sci. 120, e2218915120 (2023).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"85947_CR72","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.mad.2015.04.001","volume":"146","author":"S Martire","year":"2015","unstructured":"Martire, S., Mosca, L. & d\u2019Erme, M. PARP-1 involvement in neurodegeneration: A focus on Alzheimer\u2019s and Parkinson\u2019s diseases. Mech. Ageing Dev. 146, 53\u201364 (2015).","journal-title":"Mech. Ageing Dev."},{"key":"85947_CR73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-019-0546-4","volume":"12","author":"C Hierro-Bujalance","year":"2020","unstructured":"Hierro-Bujalance, C. et al. Empagliflozin reduces vascular damage and cognitive impairment in a mixed murine model of Alzheimer\u2019s disease and type 2 diabetes. Alzheimer\u2019s Res. Ther. 12, 1\u201313 (2020).","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"85947_CR74","doi-asserted-by":"publisher","first-page":"78104","DOI":"10.3389\/fphar.2014.00006","volume":"5","author":"C Annweiler","year":"2014","unstructured":"Annweiler, C., Karras, S. N., Anagnostis, P. & Beauchet, O. Vitamin D supplements: A novel therapeutic approach for Alzheimer patients. Front. Pharmacol. 5, 78104 (2014).","journal-title":"Front. Pharmacol."},{"key":"85947_CR75","doi-asserted-by":"publisher","first-page":"108171","DOI":"10.1016\/j.pharmthera.2022.108171","volume":"237","author":"M Eshraghi","year":"2022","unstructured":"Eshraghi, M. et al. Enhancing autophagy in Alzheimer\u2019s disease through drug repositioning. Pharmacol. Ther. 237, 108171 (2022).","journal-title":"Pharmacol. Ther."},{"key":"85947_CR76","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1093\/ndt\/gfac167","volume":"37","author":"A Mathur","year":"2022","unstructured":"Mathur, A. et al. Secondary hyperparathyroidism (CKD-MBD) treatment and the risk of dementia. Nephrol. Dial. Transplant. 37, 2111\u20132118 (2022).","journal-title":"Nephrol. Dial. Transplant."},{"key":"85947_CR77","first-page":"e12385","volume":"9","author":"J Cummings","year":"2023","unstructured":"Cummings, J. et al. Alzheimer\u2019s disease drug development pipeline: 2023. Alzheimer\u2019s Dementia 9, e12385 (2023).","journal-title":"Alzheimer\u2019s Dementia"},{"key":"85947_CR78","unstructured":"Van der Maaten, L. & Hinton, G. Visualizing data using t-SNE. J. Mach. Learn. Res. 9 (2008)."},{"key":"85947_CR79","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s12035-012-8257-x","volume":"46","author":"M Banasik","year":"2012","unstructured":"Banasik, M., Stedeford, T. & Strosznajder, R. P. Natural inhibitors of poly (ADP-ribose) polymerase-1. Mol. Neurobiol. 46, 55\u201363 (2012).","journal-title":"Mol. Neurobiol."},{"key":"85947_CR80","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.lfs.2016.02.085","volume":"150","author":"P Komirishetty","year":"2016","unstructured":"Komirishetty, P. et al. PARP inhibition attenuates neuroinflammation and oxidative stress in chronic constriction injury induced peripheral neuropathy. Life Sci. 150, 50\u201360 (2016).","journal-title":"Life Sci."},{"key":"85947_CR81","doi-asserted-by":"publisher","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","volume":"49","author":"D Szklarczyk","year":"2021","unstructured":"Szklarczyk, D. et al. The STRING database in 2021: Customizable protein\u2013protein networks, and functional characterization of user-uploaded gene\/measurement sets. Nucleic Acids Res. 49, D605\u2013D612 (2021).","journal-title":"Nucleic Acids Res."},{"key":"85947_CR82","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Kawashima, M. & Ishiguro-Watanabe, M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 51, D587\u2013D592 (2023).","journal-title":"Nucleic Acids Res."},{"key":"85947_CR83","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1038\/s41467-019-11000-7","volume":"10","author":"JS Park","year":"2019","unstructured":"Park, J. S. et al. Brain somatic mutations observed in Alzheimer\u2019s disease associated with aging and dysregulation of tau phosphorylation. Nat. Commun. 10, 3090 (2019).","journal-title":"Nat. Commun."},{"key":"85947_CR84","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41583-022-00558-9","volume":"23","author":"FG De Felice","year":"2022","unstructured":"De Felice, F. G., Gon\u00e7alves, R. A. & Ferreira, S. T. Impaired insulin signalling and allostatic load in Alzheimer disease. Nat. Rev. Neurosci. 23, 215\u2013230 (2022).","journal-title":"Nat. Rev. Neurosci."},{"key":"85947_CR85","doi-asserted-by":"publisher","first-page":"R113","DOI":"10.1016\/j.cub.2007.01.008","volume":"17","author":"ME Carter","year":"2007","unstructured":"Carter, M. E. & Brunet, A. FOXO transcription factors. Curr. Biol. 17, R113\u2013R114 (2007).","journal-title":"Curr. Biol."},{"key":"85947_CR86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-56847-4","volume":"10","author":"M Somel","year":"2020","unstructured":"Somel, M., Thornton, J. M. & D\u00f6nerta\u015f, H. M. Temporal changes in the gene expression heterogeneity during brain development and aging. Sci. Rep. 10, 1\u201315 (2020).","journal-title":"Sci. Rep."},{"key":"85947_CR87","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1038\/mp.2010.17","volume":"15","author":"K Manolopoulos","year":"2010","unstructured":"Manolopoulos, K., Klotz, L., Korsten, P., Bornstein, S. & Barthel, A. Linking Alzheimer\u2019s disease to insulin resistance: The FoxO response to oxidative stress. Mol. Psychiatry 15, 1046\u20131052 (2010).","journal-title":"Mol. Psychiatry"},{"key":"85947_CR88","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41467-020-20440-5","volume":"12","author":"J-C Park","year":"2021","unstructured":"Park, J.-C. et al. A logical network-based drug-screening platform for Alzheimer\u2019s disease representing pathological features of human brain organoids. Nat. Commun. 12, 280 (2021).","journal-title":"Nat. Commun."},{"key":"85947_CR89","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3389\/fnagi.2020.00110","volume":"12","author":"Y Yang","year":"2020","unstructured":"Yang, Y. & Zhang, Z. Microglia and Wnt pathways: Prospects for inflammation in Alzheimer\u2019s disease. Front. Aging Neurosci. 12, 110 (2020).","journal-title":"Front. Aging Neurosci."},{"key":"85947_CR90","doi-asserted-by":"publisher","first-page":"935279","DOI":"10.3389\/fnagi.2022.935279","volume":"14","author":"F Li","year":"2022","unstructured":"Li, F. et al. Weakly activated core neuroinflammation pathways were identified as a central signaling mechanism contributing to the chronic neurodegeneration in Alzheimer\u2019s disease. Front. Aging Neurosci. 14, 935279 (2022).","journal-title":"Front. Aging Neurosci."},{"key":"85947_CR91","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nrd2683","volume":"8","author":"J Jia","year":"2009","unstructured":"Jia, J. et al. Mechanisms of drug combinations: Interaction and network perspectives. Nat. Rev. Drug Discov. 8, 111\u2013128 (2009).","journal-title":"Nat. Rev. Drug Discov."},{"key":"85947_CR92","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1093\/brain\/awab134","volume":"144","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y. et al. Amyloid-\u03b2 toxicity modulates tau phosphorylation through the PAX6 signalling pathway. Brain 144, 2759\u20132770 (2021).","journal-title":"Brain"},{"key":"85947_CR93","doi-asserted-by":"publisher","first-page":"eaaz8697","DOI":"10.1126\/scitranslmed.aaz8697","volume":"13","author":"Q Lei","year":"2021","unstructured":"Lei, Q. et al. Extracellular vesicles deposit PCNA to rejuvenate aged bone marrow\u2013derived mesenchymal stem cells and slow age-related degeneration. Science Translational Medicine 13, eaaz8697 (2021).","journal-title":"Science Translational Medicine"},{"key":"85947_CR94","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.ccell.2020.09.014","volume":"38","author":"BM Kuenzi","year":"2020","unstructured":"Kuenzi, B. M. et al. Predicting drug response and synergy using a deep learning model of human cancer cells. Cancer Cell 38, 672-684.e676 (2020).","journal-title":"Cancer Cell"},{"key":"85947_CR95","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1109\/TNN.2008.2005605","volume":"20","author":"F Scarselli","year":"2008","unstructured":"Scarselli, F., Gori, M., Tsoi, A. C., Hagenbuchner, M. & Monfardini, G. The graph neural network model. IEEE Trans. Neural Netw. 20, 61\u201380 (2008).","journal-title":"IEEE Trans. Neural Netw."},{"key":"85947_CR96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12874-021-01383-x","volume":"21","author":"C Belthangady","year":"2021","unstructured":"Belthangady, C., Stedden, W. & Norgeot, B. Minimizing bias in massive multi-arm observational studies with BCAUS: Balancing covariates automatically using supervision. BMC Med. Res. Methodol. 21, 1\u201310 (2021).","journal-title":"BMC Med. Res. Methodol."},{"key":"85947_CR97","doi-asserted-by":"publisher","first-page":"104089","DOI":"10.1016\/j.engappai.2020.104089","volume":"97","author":"D Wu","year":"2021","unstructured":"Wu, D. & Wang, G. G. Causal artificial neural network and its applications in engineering design. Eng. Appl. Artif. Intell. 97, 104089 (2021).","journal-title":"Eng. Appl. Artif. Intell."},{"key":"85947_CR98","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41746-022-00632-7","volume":"5","author":"H Zheng","year":"2022","unstructured":"Zheng, H. et al. Data-driven causal model discovery and personalized prediction in Alzheimer\u2019s disease. NPJ Digit. Med. 5, 137 (2022).","journal-title":"NPJ Digit. Med."},{"key":"85947_CR99","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1038\/s41380-019-0563-5","volume":"26","author":"Y Ivashko-Pachima","year":"2021","unstructured":"Ivashko-Pachima, Y. et al. Discovery of autism\/intellectual disability somatic mutations in Alzheimer\u2019s brains: Mutated ADNP cytoskeletal impairments and repair as a case study. Mol. Psychiatry 26, 1619\u20131633 (2021).","journal-title":"Mol. Psychiatry"},{"key":"85947_CR100","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/alz.12211","volume":"17","author":"S Soheili-Nezhad","year":"2021","unstructured":"Soheili-Nezhad, S., van der Linden, R. J., Olde Rikkert, M., Sprooten, E. & Poelmans, G. Long genes are more frequently affected by somatic mutations and show reduced expression in Alzheimer\u2019s disease: Implications for disease etiology. Alzheimer\u2019s Dementia 17, 489\u2013499 (2021).","journal-title":"Alzheimer\u2019s Dementia"},{"key":"85947_CR101","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.3233\/JAD-201158","volume":"79","author":"S Sragovich","year":"2021","unstructured":"Sragovich, S., Gershovits, M., Lam, J. C. K., Li, V. O. K. & Gozes, I. Putative blood somatic mutations in post-traumatic stress disorder-symptomatic soldiers: High impact of cytoskeletal and inflammatory proteins. J. Alzheimer\u2019s Dis. 79, 1723\u20131734 (2021).","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"85947_CR102","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3233\/JAD-220643","volume":"90","author":"J Downey","year":"2022","unstructured":"Downey, J., Lam, J. C. K., Li, V. O. K. & Gozes, I. Somatic mutations and Alzheimer\u2019s disease. J. Alzheimer\u2019s Dis. 90, 475\u2013493 (2022).","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"85947_CR103","unstructured":"Alzforum. Adieu to Aduhelm: Biogen Stops Marketing Antibody, https:\/\/www.alzforum.org\/news\/community-news\/adieu-aduhelm-biogen-stops-marketing-antibody (2024)."},{"key":"85947_CR104","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1001\/jama.2021.3854","volume":"325","author":"GC Alexander","year":"2021","unstructured":"Alexander, G. C., Emerson, S. & Kesselheim, A. S. Evaluation of aducanumab for Alzheimer disease: Scientific evidence and regulatory review involving efficacy, safety, and futility. Jama 325, 1717\u20131718 (2021).","journal-title":"Jama"},{"key":"85947_CR105","doi-asserted-by":"publisher","first-page":"113945","DOI":"10.1016\/j.bcp.2020.113945","volume":"177","author":"K Mullane","year":"2020","unstructured":"Mullane, K. & Williams, M. Alzheimer\u2019s disease beyond amyloid: Can the repetitive failures of amyloid-targeted therapeutics inform future approaches to dementia drug discovery?. Biochem. Pharmacol. 177, 113945 (2020).","journal-title":"Biochem. Pharmacol."},{"key":"85947_CR106","unstructured":"Ying, Z. et al. Hierarchical graph representation learning with differentiable pooling. Adv. Neural Inf. Process. Syst. 31 (2018)."},{"key":"85947_CR107","doi-asserted-by":"crossref","unstructured":"Zhang, Q. et al. An Expert-guided Hierarchical Graph Attention Network for Post-traumatic Stress Disorder Highly-associative Genetic Biomarkers Identification. medRxiv, 2023.2001. 2030.23285175 (2023).","DOI":"10.1101\/2023.01.30.23285175"},{"key":"85947_CR108","doi-asserted-by":"publisher","first-page":"e2105070118","DOI":"10.1073\/pnas.2105070118","volume":"118","author":"W Jin","year":"2021","unstructured":"Jin, W. et al. Deep learning identifies synergistic drug combinations for treating COVID-19. Proc. Natl. Acad. Sci. 118, e2105070118 (2021).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"85947_CR109","doi-asserted-by":"publisher","first-page":"102546","DOI":"10.1016\/j.sbi.2023.102546","volume":"79","author":"O Obrezanova","year":"2023","unstructured":"Obrezanova, O. Artificial intelligence for compound pharmacokinetics prediction. Curr. Opin. Struct. Biol. 79, 102546 (2023).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"85947_CR110","doi-asserted-by":"publisher","first-page":"102827","DOI":"10.1016\/j.sbi.2024.102827","volume":"86","author":"F Abbasi","year":"2024","unstructured":"Abbasi, F. & Rousu, J. New methods for drug synergy prediction: A mini-review. Curr. Opin. Struct. Biol. 86, 102827 (2024).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"85947_CR111","doi-asserted-by":"publisher","first-page":"6184","DOI":"10.1038\/s41598-023-33271-3","volume":"13","author":"A Torkamannia","year":"2023","unstructured":"Torkamannia, A., Omidi, Y. & Ferdousi, R. SYNDEEP: A deep learning approach for the prediction of cancer drugs synergy. Sci. Rep. 13, 6184 (2023).","journal-title":"Sci. Rep."},{"key":"85947_CR112","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1021\/acs.chemrestox.0c00343","volume":"34","author":"L Liu","year":"2021","unstructured":"Liu, L. et al. Prediction of the blood\u2013brain barrier (BBB) permeability of chemicals based on machine-learning and ensemble methods. Chem. Res. Toxicol. 34, 1456\u20131467 (2021).","journal-title":"Chem. Res. Toxicol."},{"key":"85947_CR113","unstructured":"Ying, Z., Bourgeois, D., You, J., Zitnik, M. & Leskovec, J. GNNExplainer: Generating explanations for graph neural networks. Adv. Neural Inf. Process. Syst. 32 (2019)."},{"key":"85947_CR114","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart, D. S. et al. DrugBank 5.0: A major update to the DrugBank database for 2018. Nucleic Acids Res. 46, D1074\u2013D1082 (2018).","journal-title":"Nucleic Acids Res."},{"key":"85947_CR115","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41588-018-0311-9","volume":"51","author":"IE Jansen","year":"2019","unstructured":"Jansen, I. E. et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer\u2019s disease risk. Nat. Genet. 51, 404\u2013413 (2019).","journal-title":"Nat. Genet."},{"key":"85947_CR116","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-022-01603-w","author":"Y Ivashko-Pachima","year":"2022","unstructured":"Ivashko-Pachima, Y. et al. SH3-and actin-binding domains connect ADNP and SHANK3, revealing a fundamental shared mechanism underlying autism. Mol. Psychiatry https:\/\/doi.org\/10.1038\/s41380-022-01603-w (2022).","journal-title":"Mol. Psychiatry"},{"key":"85947_CR117","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.biopsych.2021.09.018","volume":"92","author":"G Karmon","year":"2021","unstructured":"Karmon, G. et al. Novel ADNP syndrome mice reveal dramatic sex-specific peripheral gene expression with brain synaptic and Tau pathologies. Biol. Psychiatry 92, 81\u201395 (2021).","journal-title":"Biol. Psychiatry"},{"key":"85947_CR118","doi-asserted-by":"publisher","first-page":"e0298","DOI":"10.1097\/MD.0000000000010298","volume":"97","author":"CHR Lin","year":"2018","unstructured":"Lin, C. H. R. et al. Quantitative comorbidity risk assessment of dementia in Taiwan: A population-based cohort study. Medicine 97, e0298 (2018).","journal-title":"Medicine"},{"key":"85947_CR119","doi-asserted-by":"publisher","first-page":"e2108013118","DOI":"10.1073\/pnas.2108013118","volume":"118","author":"I Olier","year":"2021","unstructured":"Olier, I. et al. Transformational machine learning: Learning how to learn from many related scientific problems. Proc. Natl. Acad. Sci. 118, e2108013118 (2021).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"85947_CR120","doi-asserted-by":"publisher","first-page":"D1160","DOI":"10.1093\/nar\/gkaa997","volume":"49","author":"S Avram","year":"2021","unstructured":"Avram, S. et al. DrugCentral 2021 supports drug discovery and repositioning. Nucleic Acids Res. 49, D1160\u2013D1169 (2021).","journal-title":"Nucleic Acids Res."},{"key":"85947_CR121","doi-asserted-by":"publisher","first-page":"D945","DOI":"10.1093\/nar\/gkw1074","volume":"45","author":"A Gaulton","year":"2017","unstructured":"Gaulton, A. et al. The ChEMBL database in 2017. Nucleic Acids Res. 45, D945\u2013D954 (2017).","journal-title":"Nucleic Acids Res."},{"key":"85947_CR122","doi-asserted-by":"publisher","first-page":"D1045","DOI":"10.1093\/nar\/gkv1072","volume":"44","author":"MK Gilson","year":"2016","unstructured":"Gilson, M. K. et al. BindingDB in 2015: A public database for medicinal chemistry, computational chemistry and systems pharmacology. Nucleic Acids Res. 44, D1045\u2013D1053 (2016).","journal-title":"Nucleic Acids Res."},{"key":"85947_CR123","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1021\/ci400709d","volume":"54","author":"J Tang","year":"2014","unstructured":"Tang, J. et al. Making sense of large-scale kinase inhibitor bioactivity data sets: A comparative and integrative analysis. J. Chem. Inf. Model. 54, 735\u2013743 (2014).","journal-title":"J. Chem. Inf. Model."},{"key":"85947_CR124","doi-asserted-by":"publisher","first-page":"e1597","DOI":"10.1002\/wcms.1597","volume":"12","author":"X Pan","year":"2022","unstructured":"Pan, X. et al. Deep learning for drug repurposing: Methods, databases, and applications. Wiley Interdiscip. Rev. Computat. Mol. Sci. 12, e1597 (2022).","journal-title":"Wiley Interdiscip. Rev. Computat. Mol. Sci."},{"key":"85947_CR125","unstructured":"Derr, T., Ma, Y. & Tang, J. 2018 IEEE International Conference on Data Mining (ICDM). 929\u2013934 (IEEE)."},{"key":"85947_CR126","unstructured":"Kollias, G., Kalantzis, V., Id\u00e9, T., Lozano, A. & Abe, N. In: Proceedings of the AAAI Conference on Artificial Intelligence. 7211\u20137219."},{"key":"85947_CR127","unstructured":"Kipf, T. N. & Welling, M. Variational graph auto-encoders. Preprint at arXiv:1611.07308 (2016)."},{"key":"85947_CR128","unstructured":"Zhang, M. & Chen, Y. Link prediction based on graph neural networks. Adv. Neural Inf. Process. Syst. 31 (2018)."},{"key":"85947_CR129","doi-asserted-by":"publisher","first-page":"12254","DOI":"10.1073\/pnas.1201281109","volume":"109","author":"K Wood","year":"2012","unstructured":"Wood, K., Nishida, S., Sontag, E. D. & Cluzel, P. Mechanism-independent method for predicting response to multidrug combinations in bacteria. Proc. Natl. Acad. Sci. 109, 12254\u201312259 (2012).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"85947_CR130","volume-title":"The 2022 ICML Workshop on Computational Biology","author":"K Pichotta","year":"2022","unstructured":"Pichotta, K. & Tansey, W. The 2022 ICML Workshop on Computational Biology (Maryland, 2022)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85947-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85947-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85947-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T11:41:34Z","timestamp":1736941294000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85947-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":130,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["85947"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-85947-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,15]]},"assertion":[{"value":"25 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work, including contribution of six of the co-authors (VL, YH, TK, JD, IG, and JL), has been submitted for patent protection (University of Hong Kong and Tel Aviv University). All other authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2093"}}